Abstract
The usefulness of genotypic resistance tests (GRT) among HIV-1 patients with low-level virological failure (LLVF) was evaluated. Up to 78% of samples with <1,000 copies/ml were sequenced successfully. For samples with 50 to 200 copies/ml, the success rate was as high as 69%. LLVF should not deter clinicians from requesting GRT.
MeSH terms
-
Anti-HIV Agents / therapeutic use*
-
Genotype
-
HIV Infections / drug therapy*
-
HIV Infections / virology*
-
HIV-1 / drug effects*
-
HIV-1 / genetics*
-
HIV-1 / isolation & purification
-
Humans
-
Microbial Sensitivity Tests / methods
-
Mutation, Missense*
-
RNA, Viral / genetics*
-
Sequence Analysis, DNA
-
Viral Load
Substances
-
Anti-HIV Agents
-
RNA, Viral